Monoclonal Antibodies Market Size, Share & Trends Report

Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Source Type (Chimeric, Murine, Humanized, Human), By Production Type (In Vivo, In Vitro), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-280-8
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Source type Outlook (Revenue, USD Billion, 2018 - 2030)
- Murine
- Chimeric
- Humanized
- Human
Production Type Outlook (Revenue, USD Billion, 2018 - 2030)
- In Vivo
- In Vitro
Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Neurological Diseases
- Others
Global Monoclonal Antibodies: End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Hospitals
- Specialty Centers
- Others
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
    - Murine
    - Chimeric
    - Humanized
    - Human
  - North America Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
    - In Vivo
    - In Vitro
  - North America Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Neurological Diseases
    - Others
  - North America Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
    - Hospitals
    - Specialty Centers
    - Others
  - U.S.
    - U.S. Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - U.S. Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - U.S. Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - U.S. Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Canada
- Europe
- Asia Pacific
  - Asia Pacific Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
    - Murine
    - Chimeric
    - Humanized
    - Human
  - Asia Pacific Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
    - In Vivo
    - In Vitro
  - Asia Pacific Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Neurological Diseases
    - Others
  - Asia Pacific Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
    - Hospitals
    - Specialty Centers
    - Others
  - Japan
    - Japan Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Japan Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Japan Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Japan Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - China
    - China Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - China Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - China Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - China Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - India
    - India Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - India Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - India Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - India Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Australia
    - Australia Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Australia Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Australia Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Australia Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - South Korea
    - South Korea Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - South Korea Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - South Korea Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - South Korea Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Thailand
    - Thailand Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Thailand Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Thailand Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Thailand Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
- Latin America
  - Latin America Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
    - Murine
    - Chimeric
    - Humanized
    - Human
  - Latin America Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
    - In Vivo
    - In Vitro
  - Latin America Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Neurological Diseases
    - Others
  - Latin America Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
    - Hospitals
    - Specialty Centers
    - Others
  - Brazil
    - Brazil Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Brazil Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Brazil Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Brazil Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Mexico
    - Mexico Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Mexico Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Mexico Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Mexico Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Argentina
    - Argentina Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Argentina Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Argentina Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Argentina Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
- MEA
  - MEA Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
    - Murine
    - Chimeric
    - Humanized
    - Human
  - MEA Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
    - In Vivo
    - In Vitro
  - MEA Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
    - Oncology
    - Autoimmune Diseases
    - Infectious Diseases
    - Neurological Diseases
    - Others
  - MEA Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
    - Hospitals
    - Specialty Centers
    - Others
  - South Africa
    - South Africa Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - South Africa Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - South Africa Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - South Africa Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Saudi Arabia
    - Saudi Arabia Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Saudi Arabia Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Saudi Arabia Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Saudi Arabia Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - UAE
    - UAE Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - UAE Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - UAE Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - UAE Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Kuwait
    - Kuwait Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Kuwait Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Kuwait Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Kuwait Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Kenya
    - Kenya Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Kenya Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Kenya Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Kenya Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Zimbabwe
    - Zimbabwe Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Zimbabwe Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Zimbabwe Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Zimbabwe Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Egypt
    - Egypt Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Egypt Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Egypt Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Egypt Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Nigeria
    - Nigeria Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Nigeria Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Nigeria Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Nigeria Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Morocco
    - Morocco Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Morocco Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Morocco Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Morocco Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others
  - Algeria
    - Algeria Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
      - Murine
      - Chimeric
      - Humanized
      - Human
    - Algeria Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
      - In Vivo
      - In Vitro
    - Algeria Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
      - Oncology
      - Autoimmune Diseases
      - Infectious Diseases
      - Neurological Diseases
      - Others
    - Algeria Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
      - Hospitals
      - Specialty Centers
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.